 | Up a level |
2022
Ratz, L., Brambillasca, C., Bartke, L., Huetzen, M., Goergens, J., Leidecker, O., Jachimowicz, R., van de Ven, M., Proost, N., Siteur, B., de Korte-Grimmerink, R., Bouwman, P., Pulver, E. M., de Bruijn, R., Isensee, J., Hucho, T., Pandey, G., van Lohuizen, M., Mallmann, P., Reinhardt, H. C., Jonkers, J. and Puppe, J. (2022). Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E146 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
2017
Riabinska, A., Schmitt, A., Fritz, C., Knittel, G., Torgovnick, A., Heneweer, C., Wittersheim, M., Frenzel, L., Wunderlich, C., Jachimowicz, R., Merseburg, A., Persigehl, T., Wunderlich, T., Buettner, R. and Reinhardt, H. C. (2017). Restoration of Atm induces lymphoma regression in vivo and is mediated by cell autonomous and non-cell autonomous mechanisms. Oncol. Res. Treat., 40. S. 40 - 41. BASEL: KARGER. ISSN 2296-5262